| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 10/02/2001 | CA2020668C Fused or hybrid protein comprising viral antigen and lymphokine |
| 09/27/2001 | WO2001071309A2 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | WO2001071021A1 Process for producing l-amino acid via fermentation method |
| 09/27/2001 | WO2001071012A1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070998A1 Talaromyces emersonii beta-glucanases |
| 09/27/2001 | WO2001070996A1 Method for desulfurization of dibenzothiophene using a recombinant pseudomonas putida strain as biocatalyst |
| 09/27/2001 | WO2001070990A1 Nucleic acid sequences comprising at least a phage-resistance mechanism, plasmids containing same, lactic acid bacteria and use |
| 09/27/2001 | WO2001070989A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 09/27/2001 | WO2001070988A2 Receptors for hypersensitive response elicitors and uses thereof |
| 09/27/2001 | WO2001070987A2 Novel inflorescence meristem development gene, promoter, and methods of use for same |
| 09/27/2001 | WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | WO2001070978A2 Polypeptides and nucleic acids encoding same |
| 09/27/2001 | WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | WO2001070975A1 Novel melanin concentrating hormone receptor |
| 09/27/2001 | WO2001070970A2 Regulation of human opsin-related g protein-coupled receptor |
| 09/27/2001 | WO2001070968A2 Production of recombinant blood clotting factors in human cell lines |
| 09/27/2001 | WO2001070955A2 Identification of essential genes in prokaryotes |
| 09/27/2001 | WO2001070952A1 Human gata-5 transcription factor |
| 09/27/2001 | WO2001070946A2 Methods for in vivo diversification of single genes |
| 09/27/2001 | WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 09/27/2001 | WO2001070937A1 A new thermostable d-stereospecific dipeptidase from brevibacillus bostelensis bcs-1 and its use as a biocatalyst for the synthesis of peptides containing d-amino acids |
| 09/27/2001 | WO2001070936A1 Method of culturing microorganism |
| 09/27/2001 | WO2001070935A2 Method for supply of starter cultures having a consistent quality |
| 09/27/2001 | WO2001070934A1 Copper-tolerant yeast and pectinase produced by the copper-tolerant yeast |
| 09/27/2001 | WO2001070933A1 Multi-channel quantitative control valve apparatus |
| 09/27/2001 | WO2001070816A2 Ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | WO2001070815A1 Novel leukotriene b4 receptor |
| 09/27/2001 | WO2001070811A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070804A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070797A1 Ligand-controlled anion channels of insects |
| 09/27/2001 | WO2001070777A2 Leafy cotyledon2 genes and their uses |
| 09/27/2001 | WO2001070776A2 Nimr compositions and their methods of use |
| 09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001070637A1 Method for direct clarification of ground water polluted with nitrate |
| 09/27/2001 | WO2001070389A2 Cell patterning technique |
| 09/27/2001 | WO2001070247A2 Salmonella vaccine materials and methods |
| 09/27/2001 | WO2001070175A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | WO2001070174A2 Vegf-modulated genes and methods employing them |
| 09/27/2001 | WO2001025421B1 Materials and method for detecting interaction of cftr polypeptides |
| 09/27/2001 | WO2001020013A3 Viral replicons and viruses dependent on inducing agents |
| 09/27/2001 | WO2001019973A3 Nicotinic acetylcholine receptor: alpha10 subunit |
| 09/27/2001 | WO2001018232A3 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene |
| 09/27/2001 | WO2001016176A3 Transgenic animal model for neurodegenerative diseases |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001014533A3 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 09/27/2001 | WO2001014532A3 Alkaline bacillus amylase |
| 09/27/2001 | WO2001014419A3 Growth-enhancing media for mycobacteria |
| 09/27/2001 | WO2001010903A3 Proteases and protease inhibitors |
| 09/27/2001 | WO2001009178A3 Human chaperone proteins |
| 09/27/2001 | WO2001007589A3 Dna sequences encoding lipopeptide synthases |
| 09/27/2001 | WO2001007588A3 Dna sequences which code nodulation factors |
| 09/27/2001 | WO2000041707A3 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 09/27/2001 | US20010025114 Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass |
| 09/27/2001 | US20010025100 Translation initiation factor 4AIII, and methods of use thereof |
| 09/27/2001 | US20010024828 Waste water treatment |
| 09/27/2001 | US20010024819 Comprising an effective amount of a first buffer having a pKa of 6.6-7.5, a second buffer having a pKa of 7.5-8.0, an effective amount of free RNA, an effective amount of an RNase enzyme, bacterial nutrients |
| 09/27/2001 | US20010024818 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 09/27/2001 | US20010024817 Viral nucleotide sequences |
| 09/27/2001 | US20010024814 Recognizes a specific sugar chain structure in a saccharide and introduces a n-acetylglucosamine beta 1-4 branching structure |
| 09/27/2001 | US20010024813 Human dendriac and brainiac-3 |
| 09/27/2001 | US20010024793 Nucleic acid-free thermostable enzymes and methods of production thereof |
| 09/27/2001 | US20010024653 Recombinant mycobacterium strain containing in its chromosome or on a plasmid a counterpart to a gene (which has been deactivated) in the wild type mycobacterium coding for a protein necessary for biosynthesis of a purine or pyrimidine |
| 09/27/2001 | DE10014546A1 Für das dapC-Gen kodierende Nukleotidsequenzen und Verfahren zur Herstellung von L-Lysin DapC gene coding for the nucleotide sequences and methods for producing L-lysine |
| 09/27/2001 | DE10014085A1 Cytochrome P450 monooxygenase for oxidizing organic compounds, useful especially for converting indole to indigo, has wide substrate range |
| 09/27/2001 | DE10013732A1 New DNA sequence encoding potassium channel KCNQ5, useful in screening for specific modulators, potential agents for treating central nervous system and cardiovascular diseases |
| 09/27/2001 | DE10011728A1 Verfahren zur Leistungssteigerung mikrobieller Systeme A method for performance improvement of microbial systems |
| 09/27/2001 | CA2689798A1 Talaromyces emersonii beta-glucanases |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404260A1 Identification of essential genes in prokaryotes |
| 09/27/2001 | CA2404253A1 Novel ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | CA2404216A1 Novel polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | CA2403809A1 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | CA2403804A1 Vegf-modulated genes and methods employing them |
| 09/27/2001 | CA2403795A1 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | CA2403669A1 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2403486A1 Talaromyces emersonii beta-glucanases |
| 09/27/2001 | CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | CA2403434A1 Human gata-5 transcription factor |
| 09/27/2001 | CA2403398A1 Method for supply of starter cultures having a consistent quality |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402737A1 Cell patterning technique |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2402380A1 Leafy cotyledon2 genes and their uses |
| 09/27/2001 | CA2402285A1 Nimr compositions and their methods of use |
| 09/27/2001 | CA2402252A1 Salmonella vaccine materials and methods |
| 09/27/2001 | CA2401987A1 Receptors for hypersensitive response elicitors and uses thereof |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | CA2400638A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | CA2374265A1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/26/2001 | EP1136559A2 Nucleotide sequences coding for the dapC-gene and process for the preparation of L-lysine |